2021 EULAR points to consider to support people with rheumatic and musculoskeletal diseases to participate in healthy and sustainable paid work
- 15 September 2022
- journal article
- review article
- Published by Elsevier in Annals of the Rheumatic Diseases
- Vol. 82 (1) , 57-64
Abstract
Aim As part of its strategic objectives for 2023, EULAR aims to improve the work participation of people with rheumatic and musculoskeletal diseases (RMDs). One strategic initiative focused on the development of overarching points to consider (PtC) to support people with RMDs in healthy and sustainable paid work participation. Methods EULAR’s standardised operating procedures were followed. A steering group identified six research areas on paid work participation. Three systematic literature reviews, several non-systematic reviews and two surveys were conducted. A multidisciplinary taskforce of 25 experts from 10 European countries and Canada formulated overarching principles and PtC after discussion of the results of literature reviews and surveys. Consensus was obtained through voting, with levels of agreement obtained anonymously. Results Three overarching principles and 11 PtC were formulated. The PtC recognise various stakeholders are important to improving work participation. Five PtC emphasise shared responsibilities (eg, obligation to provide active support) (PtC 1, 2, 3, 5, 6). One encourages people with RMDs to discuss work limitations when necessary at each phase of their working life (PtC 4) and two focus on the role of interventions by healthcare providers or employers (PtC 7, 8). Employers are encouraged to create inclusive and flexible workplaces (PtC 10) and policymakers to make necessary changes in social and labour policies (PtC 9, 11). A research agenda highlights the necessity for stronger evidence aimed at personalising work-related support to the diverse needs of people with RMDs. Conclusion Implementation of these EULAR PtC will improve healthy and sustainable work participation of people with RMDs.Keywords
Funding Information
- Suzanne Verstappen is supported by the NIHR Manchester Biomedical Research Centre and Versus Arthritis. (21755)
- European League Against Rheumatism (PtC)
This publication has 45 references indexed in Scilit:
- Biological vs Conventional Combination Treatment and Work Loss in Early Rheumatoid ArthritisJAMA Internal Medicine, 2013
- Effect of biological therapy on work participation in patients with ankylosing spondylitis: a systematic reviewAnnals of the Rheumatic Diseases, 2012
- The effect of biological agents on work participation in rheumatoid arthritis patients: a systematic reviewAnnals of the Rheumatic Diseases, 2012
- ICF Core Set for vocational rehabilitation: results of an international consensus conferenceDisability and Rehabilitation, 2011
- Measuring the Impact of Arthritis on Worker Productivity: Perspectives, Methodologic Issues, and Contextual FactorsThe Journal of Rheumatology, 2011
- Work disability in psoriatic arthritis: a systematic reviewRheumatology, 2011
- Work disability remains a major problem in rheumatoid arthritis in the 2000s: data from 32 countries in the QUEST-RA StudyArthritis Research & Therapy, 2010
- The assessment of efforts to return to work in the European UnionEuropean Journal of Public Health, 2010
- Employment and work disability in systemic lupus erythematosus: a systematic reviewRheumatology, 2008
- Overview of work disability in rheumatoid arthritis patients as observed in cross‐sectional and longitudinal surveysArthritis Care & Research, 2004